{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:32:16Z","timestamp":1773268336072,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2004,1,15]]},"DOI":"10.1086\/380790","type":"journal-article","created":{"date-parts":[[2004,1,6]],"date-time":"2004-01-06T17:24:08Z","timestamp":1073409848000},"page":"263-270","source":"Crossref","is-referenced-by-count":141,"title":["Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus\u2013Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study"],"prefix":"10.1093","volume":"38","author":[{"given":"Grace A.","family":"McComsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegrid M.","family":"Hessenthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Sension","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Shalit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Tyler","family":"Lonergan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime E.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV\u20101\u2010Positive Subjects (TARHEEL; ESS40010) Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_754","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023010-00004"},{"key":"rf2_755","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00002"},{"key":"rf3_756","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)90004-3"},{"key":"rf4_757","unstructured":"John M. Relative contribution of NRTIs, NNRTIs and PIs to chronic asymptomatic lactic acidemia in HIV-patients [abstract O-01]. In: Proceedings of the 1st European Symposium on Lipodystrophy and HIV-Infection (Marrakech, Morocco). Barcelona, Spain: IrsiCaixa Foundation, 2000."},{"key":"rf5_758","first-page":"L11","volume":"8","author":"Caron M","year":"2003","journal-title":"Antivir Ther"},{"key":"rf6_759","first-page":"L16","volume":"8","author":"Hammond E","year":"2003","journal-title":"Antivir Ther"},{"key":"rf7_760","first-page":"546","volume":"10","author":"Collins E","year":"2000","journal-title":"AIDS Read"},{"key":"rf8_761","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124030-00001"},{"key":"rf9_762","unstructured":"Kasper T, Arboleda CH. The impact of patient perceptions of body shape changes and metabolic abnormalities on antiretroviral therapy [poster WePpB1380]. In: Program and abstracts of the XIII International AIDS Conference (Durban, South Africa). Stockholm: International AIDS Society, 2000."},{"key":"rf10_763","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.2.207"},{"key":"rf11_764","unstructured":"Saint-Marc T. Effects of switching NRTIs [session 6]. In: Proceedings of the 1st European Symposium on Lipodystrophy and HIV-Infection (Marrakech, Morocco). 2000."},{"key":"rf12_765","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, etal Reversibility of peripheral fat wasting (lipoatrophy) on stopping stavudine therapy [abstract 52]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf13_766","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(02)01003-1"},{"key":"rf14_767","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00010"},{"key":"rf15_768","first-page":"L39","volume":"7","author":"Garcia-Benayas T","year":"2002","journal-title":"Antivir Ther"},{"key":"rf16_769","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00009"},{"key":"rf17_770","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00126334-200108150-00004","volume":"27","author":"Rakotoambinina B","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf18_771","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","volume":"30","author":"Heath KV","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf19_772","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200107010-00004","volume":"27","author":"Bogner JR","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf20_773","doi-asserted-by":"publisher","DOI":"10.1086\/338811"},{"key":"rf21_774","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"rf22_775","unstructured":"McComsey G, Maa J, Gripshover B, etal Pretreatment leptin levels may predict risk of lipoatrophy while CD4 cell counts, TNF and on-treatment changes in these indices do not [abstract 78]. In: Program and abstracts of the 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (San Diego). 2002."},{"key":"rf23_776","unstructured":"John M, McKinnon E, James I, etal Randomised, controlled, open label study of revision of antiretroviral regimens from stavudine and\/or a protease inhibitor to zidovudine\/lamivudine\/abacavir to prevent or reverse lipoatrophy: 48-week data [abstract\/poster 700]. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/38\/2\/263\/6089263\/38-2-263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T16:15:35Z","timestamp":1503418535000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/380790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,15]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,15]]}},"alternative-id":["10.1086\/380790"],"URL":"https:\/\/doi.org\/10.1086\/380790","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,15]]}}}